| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/25/2005 | US6846914 Ligand for use in the treatment of tumors, injuries, thrombosis, atherosclerosis and inflammatory diseases |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846911 An isolated protein comprising a soluble CD97 alpha subunit, and soluble subunit is selected from the group alpha 1, alpha 2, and alpha 3, originate as proprotein with beta subunit |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846905 Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| 01/25/2005 | US6846883 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846804 Affinity tag of a sublancin peptide variant having a Gly-His peptide sequence fused to the C-terminal end of the mature sublancin peptide |
| 01/25/2005 | US6846803 Hybrid polynucleotide |
| 01/25/2005 | US6846677 Selective control of lignin biosynthesis in transgenic plants |
| 01/25/2005 | US6846676 In Vivo production and delivery of erythropoietin or insulinotropin for gene therapy |
| 01/25/2005 | US6846675 Skin substitutes and uses thereof |
| 01/25/2005 | US6846674 Gene, encoding a subunit of the transcription factor AP-1, of its genome is inactivated and/or a component, acting on the AP-1 transcription factor, of the signal transduction pathway is modified resulting in a modified AP-1 activity and |
| 01/25/2005 | US6846673 Recovering preferential cell for use in the propagation of human protein; obtain cells, incubate with modulators, monitor cell propagation, transform with vector contain protein and regulatory sequences, recover protein |
| 01/25/2005 | US6846672 Mitogenic oxygenase regulators |
| 01/25/2005 | US6846671 Method and polynucleotides for determining translational efficiency of a codon |
| 01/25/2005 | US6846670 Expressing heterologous nucleotide sequences in cells; obtain vascular cells, incubate with herpes virus, monitor propagation of virus in central nervous system |
| 01/25/2005 | US6846669 Preparing transgenic plants with increased biomass and oil concentrations |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament |
| 01/25/2005 | US6846662 Vertebrate telomerase genes and proteins and uses thereof |
| 01/25/2005 | US6846658 Nucleotide sequences coding nucleic acid methylase for preventing DNA degradation during gene transfer and insertion; tools to enhance efficiency of transformation |
| 01/25/2005 | US6846656 Using a microorganism having N-acetylneuraminic acid aldolase activity or N-acetylneuraminic acid synthetase activity |
| 01/25/2005 | US6846655 Using single stranded nucleotide sequences to generate pools of cloned transcription products; protein design and therapeutics; drug screening |
| 01/25/2005 | US6846653 Amplification of preferential polypeptide in bacteria; obtain cells, transform with vector coding preferential polypetide, express vector, recover polypeptide |
| 01/25/2005 | US6846652 As vaccines and anticancer agents |
| 01/25/2005 | US6846651 Comprises sequence of influenza bacterial genome and position of proteins relative to specific restriction enzyme; diagnosis and treatment of respiratory disorders; genetic mapping |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846647 Polypeptides suppressing smooth muscle cell proliferation, the encoding cDNA, and related methods |
| 01/25/2005 | US6846644 Detection of modulators or kinase activity; obtain sample containing kinase, incubate with modulators, monitor adjustment in enzyme activity, adjustment in activity indicates modulator |
| 01/25/2005 | US6846635 Multicompartment assay comprising immobilized fibers of variable length; solid phase immunoassays |
| 01/25/2005 | US6846634 Method to screen phage display libraries with different ligands |
| 01/25/2005 | US6846630 Nucleic acid encoding receptor type protein kinase |
| 01/25/2005 | US6846627 Screening for novel compounds which regulate biological interactions |
| 01/25/2005 | US6846626 Method for amplifying sequences from unknown DNA |
| 01/25/2005 | US6846625 Method for identifying validated target and assay combination for drug development |
| 01/25/2005 | US6846624 Identifying and isolating vectors containing gene regulation proteins/transcription factor; diagnostic vector for genetic engineering |
| 01/25/2005 | US6846623 LGMD gene coding for a calcium dependent protease |
| 01/25/2005 | US6846622 Tagged epitope protein transposable element |
| 01/25/2005 | US6846482 Transcription; prevention gene expression |
| 01/25/2005 | US6846481 Recombinant expression of heterologous nucleic acids in protozoa |
| 01/25/2005 | US6846136 Rotatable cutting tool |
| 01/25/2005 | CA2308292C Method of dna shuffling |
| 01/25/2005 | CA2302873C Nucleic and amino acid sequences for a novel transketolase from (mentha piperita) |
| 01/25/2005 | CA2172008C A brassica sp. gene promoter highly expressed during stigma development |
| 01/25/2005 | CA2155756C Borrelia burgdorferi spirochete specific nucleic acid probes |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005983A1 Method of diagnosing disease relating to endometriosis |
| 01/20/2005 | WO2005005665A1 Method of evaluating compound efficacious in treating obesity |
| 01/20/2005 | WO2005005664A1 Method of detecting and method of identifying nucleic acid |
| 01/20/2005 | WO2005005662A2 Secreted proteins as markers for cell differentiation |
| 01/20/2005 | WO2005005654A1 Method of screening for improved specific activity of enzymes |
| 01/20/2005 | WO2005005652A2 Methods for the identification of inhibitors of c4 long chain base hydroxylase activity in plants |
| 01/20/2005 | WO2005005650A1 Improved production of coenzyme q-10 |
| 01/20/2005 | WO2005005649A1 Method for producing organic acid |
| 01/20/2005 | WO2005005648A1 Novel process for producing optically active carboxylic acid |
| 01/20/2005 | WO2005005645A1 Negative strand rna virus replicon |
| 01/20/2005 | WO2005005644A1 Gene expression system |
| 01/20/2005 | WO2005005643A2 Chloroplast transformation of duckweed |
| 01/20/2005 | WO2005005642A1 A method of selectively producing male or female sterile plants |
| 01/20/2005 | WO2005005641A1 A method of selectively producing male or female sterile plants |
| 01/20/2005 | WO2005005640A1 A yeast model for amyloidogenic protein toxicity |
| 01/20/2005 | WO2005005638A2 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18 |
| 01/20/2005 | WO2005005637A2 Herpes simplex virus comprising a genetically modified glycoprotein d |
| 01/20/2005 | WO2005005636A1 IgM PRODUCTION BY TRANSFORMED CELL AND METHOD OF QUANTIFYING THE SAME |
| 01/20/2005 | WO2005005635A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 01/20/2005 | WO2005005634A2 siRNA EXPRESSION SYSTEM |
| 01/20/2005 | WO2005005632A2 SMALL INTERFERING RNA SPECIFIC TO SUB-UNITS $G(A), $G(A)' AND $G(B) OF THE KINASE PROTEIN CK2, AND THE APPLICATIONS OF THE SAME |
| 01/20/2005 | WO2005005628A1 Glutamine:fructose-6-phosphate amidotransferase (gfat) comprising an internal purification marker and use thereof for the screening of compounds |
| 01/20/2005 | WO2005005627A2 Applications of a new class of enzymes: sulfiredoxines. |
| 01/20/2005 | WO2005005624A1 Method of enucleation and oocyte activation in somatic cell nuclear transfer in primates |
| 01/20/2005 | WO2005005619A1 Non-inbred embryonic stem cells having good developmental potential |
| 01/20/2005 | WO2005005613A2 Dsrna induced specific and non-specific immunity in crustaceans and other invertebrates and biodelivery vehicles for use therein |
| 01/20/2005 | WO2005005610A2 Mutant adeno-associated virus virions and methods of use thereof |
| 01/20/2005 | WO2005005603A2 Method for inducing an immune response to cancer antigen |
| 01/20/2005 | WO2005005599A2 Modulation of c-reactive protein expression |
| 01/20/2005 | WO2005005598A2 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 01/20/2005 | WO2005005594A1 Nucleic acid amplifier and method of nucleic acid amplification |
| 01/20/2005 | WO2005005483A1 Emitter-binding peptides causing a change in the spectral emission properties of the emitter |
| 01/20/2005 | WO2005005482A1 Emitter-binding peptides, which cause a modification of the spectral emission characteristics of the emitter |
| 01/20/2005 | WO2005005479A1 Non-human animals expressing heterologous complement receptor type 1 (cr1) molecules on erythrocytes and uses therefor |
| 01/20/2005 | WO2005005468A1 Novel hcv core+1 protein, methods for diagnosis of hcv infections, prophylaxis, and for screening of anti-hcv agents |
| 01/20/2005 | WO2005005466A2 Nucleic and protein sequences from the hxhv virus and uses thereof |
| 01/20/2005 | WO2005005458A1 A method for cleaving proteins |
| 01/20/2005 | WO2005004907A1 Packaged virus-like particles |
| 01/20/2005 | WO2005004898A1 Drug promoting ceramide transport, base sequence for producing the drug, method of measuring activity of promoting ceramide release and method of measuring activity of promoting intermembrane ceramide transfer |
| 01/20/2005 | WO2005004893A2 Inhibition of stress-induced ligand-dependent egfr activation |
| 01/20/2005 | WO2005004879A1 Intravascular delivery of non-viral nucleic acid |
| 01/20/2005 | WO2005004794A2 Method of treating neurodegenerative disease |
| 01/20/2005 | WO2005004592A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 01/20/2005 | WO2005004585A2 Precise breeding |
| 01/20/2005 | WO2004106529A3 Wheat plants having increased tolerance to imidazolinone herbicides |
| 01/20/2005 | WO2004106527B1 Archaeon expression system |
| 01/20/2005 | WO2004106519A3 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004099243A3 Truncated forms of human dbf4, complexes with their interacting partners and methods for identification of inhibitors thereof |
| 01/20/2005 | WO2004097042A8 Sirna selection method |
| 01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |